Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease
Clinical trial NCT04325620 · COMPLETED
Trial details
- NCT number
- NCT04325620
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-10
- Primary completion
- 2020-08-03
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.